UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.33 -0.60 (-0.73%) GOLD FUTURES
2,300.40 -2.50 (-0.11%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
48,602.73 -2,199.94 (-4.33%)
RepliCel Life Sciences Inc. (RP.V)
TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
At close: 03:56PM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 3.58M |
| Enterprise value | 3.58M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.19 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 10.13 |
| Enterprise value/EBITDA | -54.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.79 |
| 52-week change 3 | -62.07% |
| S&P500 52-week change 3 | 24.19% |
| 52-week high 3 | 0.2500 |
| 52-week low 3 | 0.0400 |
| 50-day moving average 3 | 0.0574 |
| 200-day moving average 3 | 0.0897 |
Share statistics
| Avg vol (3-month) 3 | 6k |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 65M |
| Implied shares outstanding 6 | 65M |
| Float 8 | 23.06M |
| % held by insiders 1 | 62.69% |
| % held by institutions 1 | 0.00% |
| Shares short (15 Apr 2024) 4 | 869 |
| Short ratio (15 Apr 2024) 4 | N/A |
| Short % of float (15 Apr 2024) 4 | 0.00% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.00% |
| Shares short (prior month 15 Feb 2024) 4 | 13 |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 10 Aug 2016 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 10 Aug 2016 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | -19.59% |
| Operating margin (ttm) | -368.05% |
Management effectiveness
| Return on assets (ttm) | -232.72% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 353.74k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | 0.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.47M |
| Net income avi to common (ttm) | -69.29k |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 32.48k |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | 811.38k |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.13 |
| Book value per share (mrq) | -0.10 |
Cash flow statement
| Operating cash flow (ttm) | -1.99M |
| Levered free cash flow (ttm) | -1.15M |
© 2024 Yahoo. All rights reserved.